Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Making babies with never remain the same due to @OrchidInc and @noor_siddiqui_. Proud to be involved in such important tech since the beginning and so excited to be an early adopter one day. Great story on how Silicon Valley kids are being made these days from @mjnblack and… https://t.co/obHm0H4SPA
“@OrchidInc offering represent sizable scientific leap: past, similar companies sequenced >1% of an embryo’s DNA Orchid promises to sequence over 99% from just 5 cells, providing far greater insight into each embryo’s health” @noor_siddiqui_ speaks w/@mjnblack @margauxmaccoll 🔗 https://t.co/6pVE2tmsEN
The future is exciting. Embryo screening for best chance at healthy babies w/ @OrchidInc @noor_siddiqui_ + FYI best time to freeze your sperm best time was yesterday w/ @legacy @kkteily. @mjnblack & @margauxmaccoll’s latest banger is a must read: https://t.co/DyFM7uERpj https://t.co/GXEZpqbVJF
Orchid, a startup founded by Noor Siddiqui, is pioneering the use of polygenic risk scores to screen IVF embryos for future health risks. The company promises to sequence over 99% of an embryo's DNA from just five cells, a significant advancement compared to previous methods that sequenced less than 1%. This technology aims to provide prospective parents with greater insights into the health of their future children. High-profile backers of Orchid include crypto evangelists Brian Armstrong, Vitalik Buterin, Balaji Srinivasan, and tech entrepreneur Elon Musk, who has already used the service for his child. The concept of genetically screening embryos has gained traction in Silicon Valley, with some suggesting it could become mainstream, leading to the dawn of the Silicon Valley superbaby.